Search research articles
Contact Us
Filters
Showing results (291-300 of 367) with videos related to
Page
of 37
Sort By:
Translational Psychiatry
|
February 3, 2016
A high-risk group of pregnant women with elevated levels of conflict-related trauma, intimate partner violence, symptoms of depression and other forms of mental distress in post-conflict Timor-Leste
S J Rees, W Tol, M Mohsin, et al.
Cancer Metastasis Reviews
|
April 20, 2021
Gastrointestinal stromal tumor: a review of current and emerging therapies
Bayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies
R M Mohammad, K Katato, V P Almatchy, et al.
International Journal of Molecular Medicine
|
June 18, 2004
Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia
Frances W J Beck, Davi S Eilender, Mahmoud H Dandashi, et al.
AJNR. American Journal of Neuroradiology
|
January 16, 2010
Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study
H M Hussein, A L Georgiadis, G Vazquez, et al.
Oncotarget
|
November 16, 2017
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
Asfar S Azmi, Yiwei Li, Irfana Muqbil, et al.
Cancer Letters
|
October 4, 2016
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone
Irfana Muqbil, Amro Aboukameel, Sivan Elloul, et al.
Plos One
|
December 20, 2012
Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer
Guan Wang, Jing He, Jianyun Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2010
MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function
Asfar S Azmi, Amro Aboukameel, Sanjeev Banerjee, et al.
Annals of Hematology
|
March 31, 2007
A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells
Manchao Zhang, Yan Ling, Chao-Yie Yang, et al.
Page
of 37
Search research articles
Search
Showing results (291-300 of 367) with videos related to
Sort By:
Page
of 37
Translational Psychiatry
|
February 3, 2016
A high-risk group of pregnant women with elevated levels of conflict-related trauma, intimate partner violence, symptoms of depression and other forms of mental distress in post-conflict Timor-Leste
S J Rees, W Tol, M Mohsin, et al.
Cancer Metastasis Reviews
|
April 20, 2021
Gastrointestinal stromal tumor: a review of current and emerging therapies
Bayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies
R M Mohammad, K Katato, V P Almatchy, et al.
International Journal of Molecular Medicine
|
June 18, 2004
Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia
Frances W J Beck, Davi S Eilender, Mahmoud H Dandashi, et al.
AJNR. American Journal of Neuroradiology
|
January 16, 2010
Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study
H M Hussein, A L Georgiadis, G Vazquez, et al.
Oncotarget
|
November 16, 2017
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
Asfar S Azmi, Yiwei Li, Irfana Muqbil, et al.
Cancer Letters
|
October 4, 2016
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone
Irfana Muqbil, Amro Aboukameel, Sivan Elloul, et al.
Plos One
|
December 20, 2012
Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer
Guan Wang, Jing He, Jianyun Zhao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2010
MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function
Asfar S Azmi, Amro Aboukameel, Sanjeev Banerjee, et al.
Annals of Hematology
|
March 31, 2007
A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells
Manchao Zhang, Yan Ling, Chao-Yie Yang, et al.
Page
of 37